PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
10/08/2026
Voltar para busca
Dado oficial do USPTO
ICHROMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
47
Atualização mais recente
10/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 10
Data de depósito
05/12/2014
Data de registro
14/06/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/06/2023
Última transação
10/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
701
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
3
Tipo de titular
03
Localização do titular
Gang-won-do, KR
Examinador
BODRI, JOHN PETER
Localização atual
Historical data usage
Descrição da marca
The mark consists of stylized wording "ICHROMA" in red, with the "a" appearing as the Greek letter alpha.
Titulares e representantes
Titulares
BODITECH MED INC.
Representantes
Jun-Hwa Jeong RABIN & BERDO, P.C.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemical precursors for scientific purposes; Biochemical preparations for scientific purposes; biochemical for in vitro and in vivo scientific use; Biological preparationsother than for medical or veterinary purposes; Biological tissue cultures other than for medical or veterinary purposes; Biological tissue specimens for use in scientific research; Buffer solutions for scientific purposes; Buffer solutions for use in analytical chemistry; Chemically treated non-medical test strips for calibration of laboratory apparatus; Chemically treated non-medical test strips for assays in biotechnology research; Chemical preparations for scientific purposes; Chemical preparations for scientific purposesother than for medical or veterinary use; Chemical preparations for use in industry; Chemical reagents for scientific purposes; Chemical reagentsother than for medical or veterinary purposes; Chemicals for use in biotechnological product development; Chemicals for use in chromatography; Chemicals for use in science; Chemical substances for analyses in laboratoriesother than for medical or veterinary purposes; Diagnostic preparations for scientific or research use; Diagnostic preparationsother than for medical or veterinary purposes; Diagnostic reagents for scientific or research use; Diagnostic reagentsother than for medical or veterinary purposes; Enzyme preparations for industrial purposes; Enzymes derived from biotechnological processes for use in biotechnology industry; Enzymes for scientific and research purposes; Reagent paperother than for medical or veterinary purposes; Reagents for chemical analyses; Reagents for medical research; Reagents for research purposes; Reagents for scientific purposes; Reagents for use in scientific apparatus for chemical or biological analysis; Chemical test paper
Classe 5
Biological and chemical reagents for medical or veterinary purposes; Biological reagents for medical purposes or veterinary purposes; Chemical reagents for medical or veterinary purposes; Clinical diagnostic reagents for medical purposes; Swabs for medical purposes or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic reagents for medical or veterinary purposes; Diagnostic substances for medical or veterinary purposes; Diagnostic test reagents for medical or veterinary purposes; Enzyme preparations for medical or veterinary purposes; Enzymes for medical or veterinary purposes; Reagent paper for medical or veterinary purposes; Medical diagnostic test strips for measuring or detecting biochemical markers in bodily fluids; Medical diagnostic reagents and assays for testing of bodily fluids
Classe 10
Medical apparatus for clinical diagnosis of cardiac diseasetumordiabetesinfectious diseaserheumatoid arthritishormone anomaliessepsis or anemia; Medical apparatus for use in fluorescent analysis to determine the concentration of target analytes in bodily fluids; Medical apparatus for use in immunofluorescence analysis to determine the concentration of target analytes in bodily fluids; Medical apparatus for use in absorbance analysis; Medical apparatus for use in immuno assays to determine the concentration of target analytes in bodily fluids; Medical apparatus for testing bodily fluid samples; Blood testing apparatus; Microcuvettes for medical purposes; Cartridge for test stripa container for test strips specially adapted for determining the concentration of target analytes in bodily fluids; Capillary tubes for blood; Capillary tubes for delivering reagents; Capillary tubes for samples; Diagnostic apparatus for medical purposesmedical diagnostic apparatus for detecting cardiac diseasetumorhormone levelsdiabetesinfectious diseaserheumatoid arthritissepsis or anemia; Incubators for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
47 publicações encontradas
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/08/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
12/06/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
14/06/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
06/06/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/06/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/06/2023
ES8R
TEAS SECTION 8 RECEIVED
08/12/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
14/06/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
14/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/03/2016
PUBO
PUBLISHED FOR OPPOSITION
29/03/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/03/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
19/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/02/2016
DMCC
DATA MODIFICATION COMPLETED
09/02/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
08/02/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/02/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
08/02/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/02/2016
DMCC
DATA MODIFICATION COMPLETED
28/01/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/12/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/12/2015
GNRT
NON-FINAL ACTION E-MAILED
07/12/2015
CNRT
NON-FINAL ACTION WRITTEN
07/12/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/11/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/11/2015
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
17/11/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/10/2015
GNSL
LETTER OF SUSPENSION E-MAILED
02/10/2015
CNSL
SUSPENSION LETTER WRITTEN
02/10/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
02/10/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/10/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
02/10/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/10/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2015
ALIE
ASSIGNED TO LIE
31/08/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/08/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/03/2015
GNRT
NON-FINAL ACTION E-MAILED
23/03/2015
CNRT
NON-FINAL ACTION WRITTEN
23/03/2015
DOCK
ASSIGNED TO EXAMINER
20/03/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/12/2014
NWAP
NEW APPLICATION ENTERED
09/12/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ICHROMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.